Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Annovis Bio, Inc. (ANVS)
Sector: Healthcare; Industry: Biotechnology

Annovis Bio, Inc., a clinical stage drug platform company, focuses on developing compounds to address neurodegeneration. It is also developing ANVS-301, a compound in Phase 1 clinical trials to increase cognitive capability in later stages of AD and dementia; and ANVS-405, which is in preclinical study for protecting the brain after traumatic brain injury and/or stroke. The company was founded in 2008 and is based in Berwyn, Pennsylvania.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-10-12 White Mark K. Director Buy 5,000 $27.40 $137,000 No
2021-10-11 Maccecchini Maria-Luisa PRESIDENT AND CEO Buy 18,000 $27.61 $496,980 No
2020-01-31 Hoffman Michael B 10%-Owner, Director Buy 33,333 $6.00 $199,998 Yes
2020-01-31 Whelan, Jr. Robert M. Director Buy 25,000 $6.00 $150,000 Yes
2020-01-31 Bruck Claudine Director Buy 800 $6.00 $4,800 Yes
2020-01-31 Maccecchini Maria-Luisa President and CEO Buy 1,600 $6.00 $9,600 Yes
2020-02-03 McGroarty Jeffrey Brian Chief Financial Officer Buy 52,833 $6.42 $339,426 No
2020-01-31 White Mark K. Director Buy 1,734 $6.00 $10,404 Yes

Insider Smart

Delta Airlines (DAL) - From an insider's perspective: airlines are the first ones to go under due to the pandemic. A lot of concerns were raised on possible bankruptcy especially amid by the dump from Buffett. However, insiders of Delta were bold enough to buy when Buffett was fear. And Delta is the only airline bought by insiders post-Buffett-dump.

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.